SANGUEDOLCE, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 4.302
NA - Nord America 3.858
AS - Asia 3.610
SA - Sud America 655
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 11
Totale 12.508
Nazione #
US - Stati Uniti d'America 3.761
SG - Singapore 1.407
IE - Irlanda 1.388
CN - Cina 1.001
SE - Svezia 651
HK - Hong Kong 637
BR - Brasile 539
UA - Ucraina 534
RU - Federazione Russa 478
IT - Italia 432
VN - Vietnam 226
DE - Germania 222
FR - Francia 150
FI - Finlandia 128
IN - India 122
GB - Regno Unito 115
TR - Turchia 70
CA - Canada 46
AR - Argentina 41
CZ - Repubblica Ceca 40
MX - Messico 30
AT - Austria 23
ZA - Sudafrica 22
BD - Bangladesh 21
ES - Italia 21
NL - Olanda 20
ID - Indonesia 19
PL - Polonia 19
BE - Belgio 18
EC - Ecuador 16
VE - Venezuela 16
IQ - Iraq 14
CL - Cile 13
JP - Giappone 12
AU - Australia 11
EU - Europa 11
GR - Grecia 11
AE - Emirati Arabi Uniti 10
UZ - Uzbekistan 10
KE - Kenya 9
LT - Lituania 9
PE - Perù 9
CO - Colombia 8
EG - Egitto 8
PK - Pakistan 8
PY - Paraguay 8
BA - Bosnia-Erzegovina 6
CH - Svizzera 6
CR - Costa Rica 6
SA - Arabia Saudita 6
IR - Iran 5
LV - Lettonia 5
MA - Marocco 5
AL - Albania 4
AM - Armenia 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
IL - Israele 4
LB - Libano 4
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
ET - Etiopia 3
KG - Kirghizistan 3
NP - Nepal 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
KZ - Kazakistan 2
MG - Madagascar 2
MK - Macedonia 2
OM - Oman 2
PH - Filippine 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
GE - Georgia 1
GF - Guiana Francese 1
HT - Haiti 1
JM - Giamaica 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
Totale 12.500
Città #
Dublin 1.387
Singapore 659
Hong Kong 637
Chandler 487
Nyköping 481
Ashburn 365
Jacksonville 362
Dallas 241
Dearborn 222
Beijing 209
New York 208
Santa Clara 207
Nanjing 168
Princeton 142
Munich 113
Moscow 111
Wilmington 91
The Dalles 89
Nanchang 78
Ho Chi Minh City 73
Helsinki 66
Los Angeles 64
São Paulo 58
Shenyang 53
San Mateo 52
Hanoi 43
Rome 41
Ann Arbor 40
Bari 38
Boardman 38
Milan 30
Tianjin 28
Foggia 27
Hebei 27
London 25
Brno 24
Jiaxing 24
Kunming 23
Shanghai 23
Jinan 22
Nuremberg 22
Pune 22
Rio de Janeiro 22
Brooklyn 21
Guangzhou 21
Hangzhou 19
Turku 19
Brussels 18
Changsha 18
Des Moines 18
Seattle 18
Belo Horizonte 16
Chicago 16
San Francisco 16
Warsaw 14
Olomouc 13
Frankfurt am Main 12
Haiphong 12
Montreal 12
Naples 12
Vienna 12
Brasília 11
Falkenstein 11
Reading 11
San Jose 11
Zhengzhou 11
Düsseldorf 10
Jakarta 10
Taizhou 10
Tashkent 10
Tokyo 10
Toronto 10
Washington 10
Boston 9
Council Bluffs 9
Da Nang 9
Guayaquil 9
Johannesburg 9
Ningbo 9
Norwalk 9
Assago 8
Borås 8
Chengdu 8
Denver 8
Phoenix 8
Porto Alegre 8
Redwood City 8
Thái Nguyên 8
Woodbridge 8
Wuhan 8
Atlanta 7
Biên Hòa 7
Changchun 7
Chennai 7
Genoa 7
Madrid 7
Marousi 7
Orange 7
Ottawa 7
Pescara 7
Totale 7.767
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 204
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 196
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 187
A recurrent epidermoid cyst of the spleen: report of a case and literature review 158
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 142
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 139
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 138
Un caso di sarcoma di Kaposi viscerale in un paziente con morbo di crohn duodenale e immunodeficienza congenita. 135
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 134
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 130
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 129
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 126
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 126
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 124
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 121
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 118
One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report 118
Can inspection of the mouth help clinicians diagnose Crohn's disease? A review 117
Surgicel (R) granuloma mimicking ovarian cancer: A case report 116
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 116
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 115
Role of age in prostate and bladder cancer. A critical overview 115
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 114
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 114
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 112
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 110
Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review 110
Asymptomatic solitary bladder plasmocytoma: A case report and literature review 109
An unusual delayed complication of paraffin self-injection for penile girth augmentation. 107
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 107
Hemoperitoneum due to breaking uterine adenosarcoma located in the omentum. Report of a case 107
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation 107
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 106
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 106
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 104
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 103
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 102
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 100
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 98
ARE WE DOING OUR BEST TO PREVENT THE (UNEXPECTED) DISAPPOINTING SIDE EFFECTS OF AN OTHERWISE SUCCESSFUL CANCER TREATMENT? 97
Surgicel® granuloma mimicking ovarian cancer: A case report 97
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 96
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 96
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 96
Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment 96
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 94
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 94
Ectopic manifestation of a cholesterol granuloma in the nasopalatine duct 93
Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm 92
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 91
Epidermoid cyst of the coronal sulcus mimicking penile cancer: a case report. 90
Daily tadalafil for the chronic phase of stuttering priapism: A case report 90
Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use? 89
p-NFkB expression in thyroid cancer. 89
Pilonidal cyst of the penis mimicking carcinoma. 88
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 88
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 88
Magnetic resonance imaging of penile paraffinoma: Case report 87
Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. 86
Molecular markers in bladder cancer: Novel research frontiers 84
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 84
Asymptomatic bladder metastasis from breast cancer. 83
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 83
Modulation of complement activation by pentraxin-3 in prostate cancer 83
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 82
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy 81
N-cadherin up-regulation in aggressive oral squamous cell carcinoma. 80
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 80
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 79
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 77
The complex relationship between upper urinary tract and bladder cancer: Clinical and predictive issues 77
Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets 77
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 76
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report 76
Elderly patients and prostate biopsy. How old is too old? 76
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 75
Prostate cancer biomarkers: a practical review based on different clinical scenarios 75
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications 74
Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell-renal cell carcinoma 73
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  72
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 71
Micropapillary bladder cancer, a variant histology of the elderly 71
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 71
Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma. 70
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 70
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 70
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 68
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 68
Urinary tract large cell neuroendocrine carcinoma: Diagnostic, prognostic and therapeutic issues 66
The broad landscape of follicular lymphoma: Part I 66
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 64
Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma 63
Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review 60
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 60
PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives 60
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study 59
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 58
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 58
Osseous metaplasia within a urothelial bladder cancer nodal metastasis: a case report. 58
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere? 57
Totale 9.592
Categoria #
all - tutte 88.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021354 0 0 0 0 0 12 91 34 98 99 11 9
2021/2022806 59 12 38 12 45 9 93 60 101 150 27 200
2022/20233.001 262 181 146 107 144 230 10 222 1.532 44 55 68
2023/2024823 83 37 36 20 40 283 72 38 10 23 41 140
2024/20253.205 151 51 131 62 95 360 311 141 795 457 306 345
2025/20262.649 365 442 647 745 298 152 0 0 0 0 0 0
Totale 13.073